Gallant, an animal health biotechnology company, has received eligibility for the FDA's expanded conditional approval pathway for its intravenous stem cell therapy for feline OA. 1 The pathway offers ...

New study results from Gallant showed that 76% of feline patients improved after receiving intravenous uterine-derived ...

A South Florida clinician who has translated clinical curiosity into practical teaching, Man pairs a busy general practice with a national speaking schedule and an expanding portfolio of educational ...